» Articles » PMID: 25136154

A Clinical Study of Vitiligo in a Rural Set Up of Gujarat

Overview
Date 2014 Aug 20
PMID 25136154
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Vitiligo is an acquired depigmentary condition caused by inactivation or destruction of melanocytes in epidermis and hair follicle. Worldwide incidence of 1% has been reported; similar to various dermatological clinics in India. Widespread prejudice, ignorance, taboos, lack of scientific appraisal, and confusion of vitiligo with leprosy makes it an immense psychological stress.

Aim: To know the clinical profile of vitiligo patient with associated cofactors.

Materials And Methods: Total 1,010 patients of vitiligo attended in outpatient department at Shree Krishna Hospital (SKH) and Matar camp, Gujarat over 1 year period from August 2011 to July 2012 were included in this study. Detail history and clinical examination of patients were done.

Results: Out of 1,010 patients 57.3% were females and 42.7 % were males. Most cases developed vitiligo by 2(nd) decade of life. Progressive course was found in 60.9 % of patients. Vitiligo vulgaris (57.8%) was most common morphological type. Most common site of onset (41.5%) and involvement (75.7%) was lower limb. Family history was present in 20.4%.

Conclusions: Vitiligo constitutes important dermatological disease especially in India. The data suggest that local epidemiological behavior of vitiligo need not be the same across different regions. Vitiligo differs substantially in various clinical aspects.

Citing Articles

Microneedling and 5-Fluorouracil in Treating Stable Vitiligo in Hitherto Unstudied High Prevalence Population.

Abhirami B, Kumar P, Mishra D Indian J Dermatol. 2024; 69(5):377-384.

PMID: 39649967 PMC: 11623419. DOI: 10.4103/ijd.ijd_1056_23.


Clinico-Epidemiological Profile of Vitiligo Among Patients Attending a Tertiary Care Centre of North-East India.

Saha D, Roy S, Ahmed R, Mahanta Sr P Cureus. 2024; 16(4):e58804.

PMID: 38784306 PMC: 11112533. DOI: 10.7759/cureus.58804.


Evaluation of polymorphisms and expression of , and genes in vitiligo patients.

Mecinska-Jundzill K, Tadrowski T, Jundzill A, Witmanowski H, Czajkowki R Postepy Dermatol Alergol. 2023; 40(2):225-233.

PMID: 37312906 PMC: 10258693. DOI: 10.5114/ada.2023.126314.


Apremilast Add-On Benefits Over Conventional Drugs (ABCD) in Unstable Non-segmental Vitiligo: A 12-Week Single-Center Randomized Controlled Trial.

Sharma S, Bhardwaj A, Dwivedi P, Yadav S, Shamim M, Singh S Cureus. 2023; 15(4):e37180.

PMID: 37153322 PMC: 10162885. DOI: 10.7759/cureus.37180.


Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of response to narrowband UVB phototherapy.

Youssef Y, Eldegla H, Elmekkawy R, Gaballah M Arch Dermatol Res. 2022; 315(3):379-386.

PMID: 35318513 PMC: 10020320. DOI: 10.1007/s00403-022-02348-w.


References
1.
Majumder P, Das S, Li C . A genetical model for vitiligo. Am J Hum Genet. 1988; 43(2):119-25. PMC: 1715367. View

2.
Howitz J, BRODTHAGEN H, Schwartz M, Thomsen K . Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol. 1977; 113(1):47-52. DOI: 10.1001/archderm.113.1.47. View

3.
Martis J, Bhat R, Nandakishore B, Shetty J . A clinical study of vitiligo. Indian J Dermatol Venereol Leprol. 2007; 68(2):92-3. View

4.
Pasricha J, Khaitan B, Dash S . Pigmentary disorders in India. Dermatol Clin. 2007; 25(3):343-52, viii. DOI: 10.1016/j.det.2007.05.004. View

5.
Das S, Majumder P, Chakraborty R, Majumdar T, Haldar B . Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol. 1985; 2(1):71-8. DOI: 10.1002/gepi.1370020107. View